These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 17211892

  • 1. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
    Buffa P, Manzella L, Consoli ML, Messina A, Vigneri P.
    Proteins; 2007 Apr 01; 67(1):1-11. PubMed ID: 17211892
    [Abstract] [Full Text] [Related]

  • 2. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T, Perego R, Kruh GD.
    Oncogene; 1996 Feb 01; 12(3):631-40. PubMed ID: 8637720
    [Abstract] [Full Text] [Related]

  • 3. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
    Nagar B, Hantschel O, Seeliger M, Davies JM, Weis WI, Superti-Furga G, Kuriyan J.
    Mol Cell; 2006 Mar 17; 21(6):787-98. PubMed ID: 16543148
    [Abstract] [Full Text] [Related]

  • 4. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
    Yu HH, Zisch AH, Dodelet VC, Pasquale EB.
    Oncogene; 2001 Jul 05; 20(30):3995-4006. PubMed ID: 11494128
    [Abstract] [Full Text] [Related]

  • 5. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB, Roumiantsev S, Van Etten RA.
    Oncogene; 2001 Nov 22; 20(53):7744-52. PubMed ID: 11753652
    [Abstract] [Full Text] [Related]

  • 6. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D, Superti-Furga G.
    Nat Genet; 1998 Mar 22; 18(3):280-2. PubMed ID: 9500553
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT, Serrano L, Wilmanns M.
    J Mol Biol; 1998 Aug 21; 281(3):513-21. PubMed ID: 9698566
    [Abstract] [Full Text] [Related]

  • 8. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
    Juang JL, Hoffmann FM.
    Oncogene; 1999 Sep 16; 18(37):5138-47. PubMed ID: 10498863
    [Abstract] [Full Text] [Related]

  • 9. Regulation of the c-Abl and Bcr-Abl tyrosine kinases.
    Hantschel O, Superti-Furga G.
    Nat Rev Mol Cell Biol; 2004 Jan 16; 5(1):33-44. PubMed ID: 14708008
    [Abstract] [Full Text] [Related]

  • 10. Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl.
    Hantschel O, Wiesner S, Güttler T, Mackereth CD, Rix LL, Mikes Z, Dehne J, Görlich D, Sattler M, Superti-Furga G.
    Mol Cell; 2005 Aug 19; 19(4):461-73. PubMed ID: 16109371
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH, Pendergast AM, Zipfel PA, Traugh JA.
    Biochemistry; 2008 Jan 22; 47(3):1094-104. PubMed ID: 18161990
    [Abstract] [Full Text] [Related]

  • 12. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
    Jackson PK, Paskind M, Baltimore D.
    Oncogene; 1993 Jul 22; 8(7):1943-56. PubMed ID: 8510937
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro.
    Plath K, Engel K, Schwedersky G, Gaestel M.
    Biochem Biophys Res Commun; 1994 Sep 15; 203(2):1188-94. PubMed ID: 8093038
    [Abstract] [Full Text] [Related]

  • 14. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
    Cowan-Jacob SW, Fendrich G, Manley PW, Jahnke W, Fabbro D, Liebetanz J, Meyer T.
    Structure; 2005 Jun 15; 13(6):861-71. PubMed ID: 15939018
    [Abstract] [Full Text] [Related]

  • 15. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration.
    Hu H, Bliss JM, Wang Y, Colicelli J.
    Curr Biol; 2005 May 10; 15(9):815-23. PubMed ID: 15886098
    [Abstract] [Full Text] [Related]

  • 16. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
    Reichman C, Singh K, Liu Y, Singh S, Li H, Fajardo JE, Fiser A, Birge RB.
    Oncogene; 2005 Dec 08; 24(55):8187-99. PubMed ID: 16158059
    [Abstract] [Full Text] [Related]

  • 17. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.
    Dorey K, Engen JR, Kretzschmar J, Wilm M, Neubauer G, Schindler T, Superti-Furga G.
    Oncogene; 2001 Dec 06; 20(56):8075-84. PubMed ID: 11781820
    [Abstract] [Full Text] [Related]

  • 18. 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases.
    Thaimattam R, Daga PR, Banerjee R, Iqbal J.
    Bioorg Med Chem; 2005 Aug 01; 13(15):4704-12. PubMed ID: 15914012
    [Abstract] [Full Text] [Related]

  • 19. The DNA binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC motif and to distorted DNA structures.
    David-Cordonnier MH, Hamdane M, Bailly C, D'Halluin JC.
    Biochemistry; 1998 Apr 28; 37(17):6065-76. PubMed ID: 9558345
    [Abstract] [Full Text] [Related]

  • 20. Homodimerization of the c-Abl protein tyrosine kinase.
    Wei L, Liu X, Yi YP, Li CF, Wang YL, Cao C.
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep 28; 21(5):698-702. PubMed ID: 16285507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.